Douglas Lorne Arnold

Douglas Lorne Arnold

McGill University - Montréal / Canada
Medical and Health Sciences / Neurology
AD Scientific Index ID: 641160
person_outline Douglas Lorne Arnold's MOST POPULAR ARTICLES
1-) Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis N Engl J Med 376 (3), 209-220, 2017
2-) Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis New England Journal of Medicine 367 (12), 1098-1107, 2012
3-) Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis N Engl J Med 376 (3), 221-234, 2017
4-) Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis N Engl J Med 376 (3), 221-234, 2017
5-) Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial The Lancet 380 (9856), 1819-1828, 2012